French David, Nadji Nabil, Shariati Batoul, Hatzimanolakis Penny, Larjava Hannu
Int J Periodontics Restorative Dent. 2016;36 Suppl:s89-97. doi: 10.11607/prd.2191.
This retrospective study with a follow-up period of 4 months to 10 years evaluated survival, success, and complication rates of implants placed using osteotome sinus floor elevation (OSFE) without added bone grafting. A total of 926 implants were placed, including 530 short implants (6 mm to 8.5 mm) and 209 implants in low residual bone height (RBH) (< 5 mm). Bone levels were evaluated at approximately 3 months and at 1, 3, and 5 years, and in some cases up to 10 years after implants were placed. The implant survival rate was 98.3% at the 5-year follow-up. Twelve of the 926 implants failed (6 preprosthetic, 6 postprosthetic). The success rate was 95.4% at a threshold of less than 1 mm of bone loss for combined systems (Straumann; Nobel Biocare). Short implant survival and success rates were statistically comparable to conventional-length implants. Low-RBH implants had a lower but acceptable survival rate of 95.7%. Adverse events were rare, with one case of infection and zero cases of vertigo reported. The findings of this study indicate that implant placement with OSFE without added bone graft is highly successful, even when short implants are used in low RBH.
这项随访期为4个月至10年的回顾性研究评估了采用骨凿上颌窦底提升术(OSFE)且未添加骨移植的种植体的存活率、成功率和并发症发生率。共植入了926颗种植体,其中包括530颗短种植体(6毫米至8.5毫米)和209颗植入低剩余骨高度(RBH)(<5毫米)的种植体。在种植体植入后约3个月、1年、3年和5年评估骨水平,在某些情况下评估至10年。5年随访时种植体存活率为98.3%。926颗种植体中有12颗失败(修复前6颗,修复后6颗)。对于联合系统(士卓曼;诺贝尔生物科技),在骨丢失小于1毫米的阈值下成功率为95.4%。短种植体的存活率和成功率在统计学上与常规长度种植体相当。低RBH种植体的存活率较低,但仍可接受,为95.7%。不良事件罕见,报告了1例感染,眩晕病例为零。本研究结果表明,即使在低RBH情况下使用短种植体,采用不添加骨移植的OSFE进行种植体植入也非常成功。